Schedule 13G ownership disclosure
GT BIOPHARMA INC
Security class unavailable · CUSIP: 36254L209
Event date: 2021-02-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-21-000488
- Form type
- SC 13G
- Filer
- BIGGER CAPITAL FUND L P
- CIK
- CIK 1288478
- Filed
- Feb 17, 2021
- Reporting period
- Feb 11, 2021
- Description
- Schedule 13G beneficial ownership